ArticleCancer cell international2017

MiR-7 inhibits progression of hepatocarcinoma by targeting KLF-4 and promises a novel diagnostic biomarker.

Weizhong Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.